SCHEMBL30987698

SCHEMBL30987698

COC(=O)c1ccc2c(c1)c(C1CCCC1)nn2C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
NPSR1 Q6W5P4 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
ATM Q13315 1/20 0.43
CNR1 P21554 2/20 0.42
PDE4D Q08499 2/20 0.42
PDE7A Q13946 2/20 0.42
KDM4E B2RXH2 3/20 0.40
MAPT P10636 2/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
HPGD P15428 2/20 0.40
CACNA1H O95180 1/20 0.40
LMNA P02545 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
SCARB1 Q8WTV0 2/20 0.39
HTR3A P46098 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18561353 0.90 CNR1 (0.45) ALDH1A1NPSR1SMN1; SMN2CNR1KDM4E
SCHEMBL30159624 0.85 CYP1A2 (0.43) ALDH1A1NPSR1SMN1; SMN2ATMCNR1
SCHEMBL30987789 0.85 CNR1 (0.46) CNR1HPGDCACNA1HHTR3ACYSLTR2
SCHEMBL23535801 0.85 CYP1A2 (0.43) ALDH1A1NPSR1SMN1; SMN2ATMCNR1
SCHEMBL30987685 0.81 CNR1 (0.46) CNR1PDE4DKDM4EMAPT
SCHEMBL30987726 0.81 CNR1 (0.46) CNR1PDE4DKDM4EMAPT
SCHEMBL28470034 0.80 DDB1 (0.43) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL10324566 0.78 DGAT2 (0.39) ALDH1A1NPSR1SMN1; SMN2ATMCNR1
SCHEMBL30159688 0.78 DGAT2 (0.39) ALDH1A1NPSR1SMN1; SMN2ATMCNR1
SCHEMBL28469672 0.78 CHRNB2 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4676929-A1 PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 Dark Blue Therapeutics Ltd (GB) 2026-01-14 EP disclosed
EP-4638447-A1 IMIDAZO[1,2-A]PYRIDINE AND IMIDAZO[1,2-A]PYRAZINE DERIVATIVES AS MLLT1 AND MLLT3 INHIBITORS Dark Blue Therapeutics Ltd (GB) 2025-10-29 EP disclosed
WO-2024188906-A1 PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 DARK BLUE THERAPEUTICS LTD (GB) 2024-09-19 WO disclosed
WO-2024133560-A1 IMIDAZO[1,2-A]PYRIDINE AND IMIDAZO[1,2-A]PYRAZINE DERIVATIVES AS MLLT1 AND MLLT3 INHIBITORS DARK BLUE THERAPEUTICS LTD (GB) 2024-06-27 WO disclosed